CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 6325-6601 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T39","span":{"begin":0,"end":276},"obj":"Sentence"}],"text":"These studies found that active lesions are significantly reduced in NAA, and that as the disease progresses from the relapsing-remitting phase to the chronic-progressive phase, a reduction in NAA can be measured even in normal-appearing white matter (Matthews et al., 1996) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T39","span":{"begin":0,"end":276},"obj":"Sentence"},{"id":"TextSentencer_T39","span":{"begin":0,"end":276},"obj":"Sentence"},{"id":"T29824","span":{"begin":0,"end":276},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These studies found that active lesions are significantly reduced in NAA, and that as the disease progresses from the relapsing-remitting phase to the chronic-progressive phase, a reduction in NAA can be measured even in normal-appearing white matter (Matthews et al., 1996) ."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T14","span":{"begin":238,"end":250},"obj":"Body_part"},{"id":"T15","span":{"begin":238,"end":243},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_0002316"},{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0002316"}],"text":"These studies found that active lesions are significantly reduced in NAA, and that as the disease progresses from the relapsing-remitting phase to the chronic-progressive phase, a reduction in NAA can be measured even in normal-appearing white matter (Matthews et al., 1996) ."}